Instem plc Issue of Equity, TVRs & PDMR Dealing (2507L)

TIDMINS

RNS Number : 2507L

Instem plc

17 July 2017

Instem plc

("Instem" or the "Company")

Issue of Equity, Total Voting Rights and PDMR Dealing

Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that, following the exercise of vested EMI share options by an employee, 1,500 ordinary shares of 10p each in the Company ("Ordinary Shares") have been issued.

Application will be made to the London Stock Exchange for the admission of the 1,500 new Ordinary Shares to trading on AIM. Admission is expected to take place at 8.00am on 19 July 2017.

Total Voting Rights

Following the issue and allotment of the above New Ordinary Shares, the Company's issued share capital comprises 15,866,660 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of voting rights in the Company is 15,866,660.

The figure of 15,866,660 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

PDMR Dealing

The Company was notified on 13 July that on 12 July 2017, the DG 2008 Discretionary Settlement (of which David Gare (the Company chairman) and his wife are the trustees) transferred 10,000 Ordinary Shares to David's son Adrian Gare and a further 10,000 to his daughter, Debbie Walker, for nil consideration. Following the transaction, the DG 2008 Discretionary Settlement now has a total interest in 1,398,427 Ordinary Shares, representing approximately 8.81% of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging 
        managerial responsibilities / person 
        closely associated 
----  ---------------------------------------------------------------- 
 a)    Name                       David Gare (via the DG 
                                   2008 Discretionary Settlement) 
----  -------------------------  ------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------- 
 a)    Position/status            Chairman of the Company 
----  -------------------------  ------------------------------------- 
 b)    Initial notification       Initial 
        /Amendment 
----  -------------------------  ------------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, 
        auctioneer or auction monitor 
----  ---------------------------------------------------------------- 
 a)    Name                       Instem plc 
----  -------------------------  ------------------------------------- 
 b)    LEI                        213800PILYUFNNROQX68 
----  -------------------------  ------------------------------------- 
 4     Details of the transaction(s): section 
        to be repeated for (i) each type of 
        instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place 
        where transactions have been conducted 
----  ---------------------------------------------------------------- 
 a)    Description                Ordinary shares of 10p 
        of the financial           each 
        instrument, 
        type of instrument 
---- 
 
       Identification             GB00B3TQCK30 
        code 
 
 b)    Nature of the              Transfer of ordinary 
        transaction                shares 
----  -------------------------  ------------------------------------- 
 c)    Price(s) and 
        volume(s) 
----                              ---------------  ----------------- 
                                   Price(s)         Volume(s) 
----                              ---------------  ----------------- 
                                   0p               10,000 
                                  ---------------  ----------------- 
 
 d)    Aggregated 
        information 
---- 
 
       - Aggregated               N/A 
        volume 
 
       - Price 
 
 e)    Date of the                12 July 2017 
        transaction 
----  -------------------------  ------------------------------------- 
 f)    Place of the               London Stock Exchange 
        transaction                (XLON) 
----  -------------------------  ------------------------------------- 
 4     Details of the transaction(s): section 
        to be repeated for (i) each type of 
        instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place 
        where transactions have been conducted 
----  ---------------------------------------------------------------- 
 a)    Description                Ordinary shares of 10p 
        of the financial           each 
        instrument, 
        type of instrument 
---- 
 
       Identification             GB00B3TQCK30 
        code 
 
 b)    Nature of the              Transfer of ordinary 
        transaction                shares 
----  -------------------------  ------------------------------------- 
 c)    Price(s) and 
        volume(s) 
----                              ---------------  ----------------- 
                                   Price(s)         Volume(s) 
----                              ---------------  ----------------- 
                                   0p               10,000 
                                  ---------------  ----------------- 
 
 d)    Aggregated 
        information 
---- 
 
  - Aggregated               N/A 
   volume 
 
  - Price 
 
 e)    Date of the                12 July 2017 
        transaction 
----  -------------------------  ------------------------------------- 
 f)    Place of the               London Stock Exchange 
        transaction                (XLON) 
----  -------------------------  ------------------------------------- 
 

For further information, please contact:

 
 Instem plc                 [phone] 
 Phil Reason, CEO 
 Nigel Goldsmith, CFO 
 
 
   N+1 Singer (Nominated 
   Adviser & Broker)          [phone] 
 Richard Lindley 
  James White 
 
 
   Walbrook Financial PR      [phone] 
 Paul Cornelius             [e-mail] 
 Helen Cresswell 
  Sam Allen 
  Paul Whittington 
 
 

About Instem

Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit www.instem.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEBGGDRLDBBGRR

(END) Dow Jones Newswires

July 17, 2017 06:27 ET (10:27 GMT)